Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Gijn, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Gijn, J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Blood Pressure Medicines
*Stroke

(Stroke. 2002;33:319.)
© 2002 American Heart Association, Inc.


Comments, Opinions, and Reviews

The PROGRESS Trial: Preventing Strokes by Lowering Blood Pressure in Patients With Cerebral Ischemia

Emerging Therapies: Critique of an Important Advance

Jan van Gijn, MD, FRCP, FRCP(Edin)

From the Department of Neurology, University Medical Centre Utrecht, Utrecht, the Netherlands.

Correspondence to J. van Gijn, MD, FRCP, FRCP(Edin), Department of Neurology, room G03.228, University Medical Centre Utrecht, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands. E-mail J.vanGijn@neuro.azu.nl


Key Words: blood pressure • cerebral ischemia • stroke • transient ischemic attack


*    Introduction
 
A blood pressure is an unhealthy thing to have, to a large extent. Prospective population-based observational studies have shown a continuous, positive relationship between blood pressure and the risk of stroke or other major vascular events. There is no "safe" level of blood pressure below which the risk ceases to diminish. The association is even stronger than one might surmise from casual measurements, because of regression to the mean on subsequent readings. After appropriate correction, prolonged differences in usual diastolic blood pressure of 5, 7.5, and 10 mm Hg are respectively associated with at least 34%, 46%, and 56% relative risk reduction of stroke.1,2 The effectiveness of antihypertensive treatment in the primary prevention of stroke leaves no doubt about the causality of the relationship: systematic reviews show that a diastolic blood pressure reduction of 5 to 6 mm Hg results in a large decrease in stroke rate, in the order of 35% to 50%.3,4

Until now, the question remained whether blood pressure reduction was equally beneficial in patients after a transient ischemic attack (TIA) or a stroke. Theoretically, irreparable damage might already have occurred at the time of the first manifestation of cerebrovascular disease. A slightly crude analogy is that abstaining from cigarettes greatly improves prognosis in the general population but not much in patients with bronchial carcinoma. Systematic reviews showed equivocal benefit of blood pressure reduction in 4 clinical trials in which an episode of brain ischemia was the qualifying event.5 In subsets of patients with previous stroke from . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
StrokeHome page
S. S. Y. Ho and C. Metreweli
Preferred Technique for Blood Flow Volume Measurement in Cerebrovascular Disease
Stroke, June 1, 2000; 31(6): 1342 - 1345.
[Abstract] [Full Text] [PDF]